Navigation Links
Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer
Date:3/11/2008

BRISBANE, Australia, March 11 /PRNewswire-FirstCall/ -- Progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) today announced the commencement of its global phase 3 study investigating PI-88 as an adjuvant treatment for primary liver cancer (hepatocellular carcinoma, HCC) following curative resection with the first patient having been randomized onto the study. The study is known globally as PATHWAY (PI-88 in the adjuvant treatment of HCC). The first patient to enter the trial is from Singapore.

Dr. Ronnie Poon, Ph.D., M.D., global lead investigator for PATHWAY, commented, "My colleagues and I are encouraged by the phase 2 data that Progen has generated for PI-88 in this challenging disease, for which there are no approved treatment options. If PATHWAY is successful, PI-88 could change the standard of care for resected liver cancer patients."

PATHWAY, a double-blinded, placebo-controlled study, has been designed to establish the efficacy and safety of PI-88 in the post resection liver cancer setting. The trial will recruit approximately 600 patients at about 65-70 hospitals in more than a dozen countries. Disease-free survival, a measure of the average length of time that patients remain free of tumor recurrence, is the primary endpoint. Upon completion of this trial, the results are expected to form the basis of global registration filings for PI-88.

Justus Homburg, Progen's CEO, said, "Commencement of this trial represents a significant milestone for Progen. We have designed this trial in collaboration with world experts in this field of medicine, and with USA FDA Fast Track and EU EMEA Orphan Drug Status, its initiation underscores our commitment to making this important drug rapidly available to patients who currently have few treatment options available."

Liver cancer is one of the top five causes of cancer deaths in the world, with over half a million new cases per year. Although surgical resection is one of the few treatme
'/>"/>

SOURCE Progen Pharmaceuticals Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Progen Provides Update on Phase 3 Clinical Program for PI-88 in Liver Cancer
2. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
3. Progen Announces PI-88 Phase 2 Lung Cancer Results
4. Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
5. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
6. Inclinix Announces New Patent for Expert System Platform
7. Genzyme Announces Presentation of New Positive Data on Carticel(R)
8. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
9. AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin
10. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
11. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)...   Unique Pizza and Subs Corporation ... a Delaware Corporation, is pleased to announce it ... Corporation ("Larasan"), a nature-based pharmaceutical company that produces and ... Larasan will work with Unique to help distribute ... vast distribution network throughout China ...
(Date:7/30/2014)... July 30, 2014 Silicon Valley Bank, the ... study today that examines the merger, acquisition and ... companies.  According to the annual report based on 2013 ... returns since SVB started tracking the data in 2005. ... Built on solid healthcare M&A activity over the last ...
(Date:7/30/2014)... LONDON , July 30, 2014  Lightlake ... developing addiction treatments based on its expertise in ... a funding commitment from a prominent international research ... a focus on promoting innovative research-based initiatives, including ... a nasal spray for the delivery of naloxone ...
Breaking Medicine Technology:Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 2Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 3
... prioritization -, LOUISVILLE, Colo., Dec. 10 ... announced an operational restructuring to align,critical resources ... partner for Replidyne,s late-stage antibiotic, faropenem,medoxomil (faropenem), ... exploring additional corporate development opportunities., The ...
... outcomes for premature babies, FORT WORTH, Texas, ... Now, they are helping improve the care of,premature ... care unit recently implemented the use of the ... results in decreasing the,incidence of chronic lung disease ...
Cached Medicine Technology:Replidyne Provides Strategic Update 2Replidyne Provides Strategic Update 3Replidyne Provides Strategic Update 4Replidyne Provides Strategic Update 5Replidyne Provides Strategic Update 6Harris Methodist Fort Worth Hospital Using Bubbles to Help Babies Breathe 2
(Date:7/30/2014)... Daily Gossip indicates in its 60 Second Panic ... attack is a feeling of intense stress and fear, which ... of symptoms that sufferers commonly deal with when panic attacks ... or anxiety. Naturally, panic attacks deeply affect lifestyle; this is ... them. , The 60 Second Panic Solution review promises to ...
(Date:7/30/2014)... and Malaysia (PRWEB) July 30, 2014 ... through education by LTT Global an award winning mobile ... learning on the go since 2004. , MyMobileUni.com’s platform ... quality learning content. MMU has links to the ... organizations, NGOs’ and subject matter experts from all over ...
(Date:7/30/2014)... 2014 Nationally recognized leader in nursing ... since September 2013 has served as president of the ... dean of the College of Nursing at University of ... leadership of the NLN, as the nation's premier voice ... nursing and research institutions in the country. , ...
(Date:7/30/2014)... weeks freshman will begin to pour onto college campuses, each student ... time of growth and the start to something big. Statistically speaking, ... as easy as it looks. Some sources cite as ... once and many will switch two or three times. Each switch ... switching in the later years of college. According to the ...
(Date:7/30/2014)... 30, 2014 Throughout the month of ... free oral cancer screenings. Using a new technological tool ... detect the disease in its early stages. , Oral ... mouth, sinuses, throat and other areas in and around ... Epidemiology, and Ends Results (SEER) program, 30 percent of ...
Breaking Medicine News(10 mins):Health News:60 Second Panic Solution Review Reveals Unique Way to Stop Panic Attacks 2Health News:MyMobileUniversity Inviting Individuals, Who Are Passionate about the Universal Right to Education, to Come on Board as Goodwill Ambassadors 2Health News:MyMobileUniversity Inviting Individuals, Who Are Passionate about the Universal Right to Education, to Come on Board as Goodwill Ambassadors 3Health News:National League for Nursing Congratulates League President Marsha Adams on Appointment as Dean of College of Nursing at University of Alabama-Huntsville 2Health News:National League for Nursing Congratulates League President Marsha Adams on Appointment as Dean of College of Nursing at University of Alabama-Huntsville 3Health News:Advice to College Freshman from Author Garrett Miller 2Health News:Advice to College Freshman from Author Garrett Miller 3Health News:Restore Dental Offers Complimentary Oral Cancer Screenings in August 2
... actress and wife of Brad Pitt has commissioned US ... to celebrate the different stages of her pregnancy. ... her request. About the portrait. ,The painting are ... in Angelinas private collection." ,Bachardy is a ...
... pain's ability to seek attention. ,The ... is distinct from the one involved in cognitive processing ... ,The study was conducted by a team of researchers ... Center Hamburg-Eppendorf. ,As part of the study, ...
... at the Stanford University School of Medicine have identified one ... and treatments for depression converge. Scientists hunt for the ... so many treatments with different mechanisms that the condition remains ... rats the differing mechanisms of depression and its treatment in ...
... of five major breast cancer trials has confirmed that ... improves survival in women with operable HER-2 positive breast ... Dahabreh from the University of Athens reported the results ... 13,000 women whose breast cancer was amenable to surgery. ...
... designed by scientists to be safe to normal tissue but ... preliminary study, researchers said today at the ESMO Conference Lugano ... type of herpes simplex virus modified so that it selectively ... ,It doesnt replicate in normal, healthy cells, so our ...
... An Australian suffered injuries to a thigh and three other ... tourists celebrated the start of the nine-day San Fermin bullrun. ... alcohol and the "encierro", when bulls are released onto the ... (yard) course leading to the arenas where bullfights are later ...
Cached Medicine News:Health News:Researchers Say Brain Region Responsible for Pain's Ability to Seek Attention 2Health News:Brain Pathway for Depression Revealed 2Health News:Brain Pathway for Depression Revealed 3Health News:Combination of Tratuzumab and Chemotherapy Yields Better Results for Breast Cancer 2Health News:New Cancer Fighting Virus 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: